2- Tuesday  Pharmacy Practice News – 30th March

1 – Management of type 2 diabetes with oral semaglutide: Practical guidance for pharmacists

• Oral semaglutide, the first oral glucagon-like peptide 1 (GLP-1) receptor agonist (GLP-1RA), was approved for the treatment of adults with T2D by the US Food and Drug Administration in September 2019.
• This study aims to provide pharmacists with information on counseling patients with type 2 diabetes (T2D) receiving oral semaglutide.
• Information and practical strategies provided by pharmacists may facilitate initiation and maintenance of oral semaglutide therapy and ensure that each patient achieves an optimal therapeutic response

Source: Oxford Academic

2 – Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States

• In a multicenter point-prevalence study, they found that the rate of supportive care was high; among those receiving COVID-19 drug therapies, adverse reactions occurred in 12% of patients.
• The primary objective was to describe COVID-19–targeted therapies.
• The secondary objective was to describe adverse drug reactions (ADRs).
• While they observed high rates of supportive care for patients with COVID-19, we also found that ADRs were common among patients receiving drug therapy, including those enrolled in clinical trials.
• Comprehensive systems are needed to identify and mitigate ADRs associated with experimental COVID-19 treatments.

Source: Oxford Academic

3 – Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic

• Strategies for deploying clinical pharmacists to increase access to buprenorphine in inpatient, outpatient and transitional care, and community practice settings are described.
• Leveraging pharmacists to extend access to MOUD, particularly buprenorphine, remains an underutilized strategy that should be implemented, particularly during the concurrent COVID-19 global pandemic.

Source: Oxford Academic

4- A strategic approach to improving pharmacy enterprise automation: Development and initial application of the Autonomous Pharmacy Framework

• The use of technology in health-system pharmacy practice is evolving as electronic health records (EHRs), robots, packagers, and smart devices are adopted.
• These technologies greatly increase the amount of pharmacy data collected, thereby enabling more powerful and effective data-driven automation.
• Data-driven automation leverages flows of digital data throughout an enterprise to achieve improvements.

Source: Oxford Academic

5 – Pharmacists’ views and desires regarding pharmacist administration of vaccines in New Zealand

• This study aims to explore pharmacists’ views and experiences of pharmacist-administered vaccinations, motivators and barriers to pharmacists administering vaccinations and their preferences for expansions to such services.
• This study found strong support for this service, including benefits for patients, and for customer relationships. Identified barriers including service setup and patient costs could be reduced by expanding the categories (e.g. pharmacy students and technicians) of staff able to vaccinate.

Source: Oxford Academic

6 – The evolving role of community pharmacists during COVID-19 in the UAE; assessing preparedness and knowledge

• This study aims to investigate community pharmacists’ knowledge about COVID-19 and their preparedness for the pandemic.
• This cross-sectional online survey was conducted (in community pharmacies in the United Arab Emirates) over 3 weeks.
• This study indicates that years of experience and good knowledge on COVID-19 were significant determinants of pharmacists’ preparedness for the pandemic control.

Source: Oxford Academic

• Read more from FADIC Blog, with many articles with evidence based articles.
• Learn More Through FADIC® – Online Programs & Mini-Courses.
• Listen Now to FADIC Podcast focusing on varieties of pharmacist perspectives in specialties.
• Read More Now about FADIC Pharmacy Events to get more Experience.

Course Copyrights:

All Courses is meant for SINGLE user use only.
If more than one person acceced this course, they will be BLOCKED Forever.

Why FADIC 2020 Pharmacotherapy Daily News (FNN) ?

• It helps to keep up with the literature!
• Provide you with the Updated with the latest in your clinical practice. Wherever you are, and Whenever you need!
• Help you to share in the advance in clinical career. In addition to adding an impressive image to the pharmacists all-around!

Subscribe to FADIC 2021 Pharmacy Practice FNN E-News, for publication of:

Read & Download FNN Issue 8 of April 2020 FNN News